Leading market analysts have flagged fresh high-conviction trading ideas for the near term, with a mixed bag of buy and sell ...

Explore defensive investment strategies in healthcare and pharma sectors as opportunities arise amidst market volatility and ...

Discover the Divis Labs Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

While HDFC Securities has assigned a 'Buy' rating to Divi's Labs, Sai Life Sciences, and Piramal Pharma, it has given an 'Add ...

Jefferies' top picks in the CRDMO space are Sai Lifesciences and Divi’s for strong execution and healthy growth outlook.

Market expert Raja Venkatraman shares his top three stock picks to buy today, 7 January. Discover his exclusive picks and ...

Amid the rising volatility in the Indian equity markets, domestic brokerage firm BP Equities has shared its top picks for ...

Vinay Rajani of HDFC Securities says Divis Labs share price has broken out from the box pattern on the daily chart with the ...

On Wednesday, market technical analysts Chandan Taparia, Vinay Rajani and Mitessh Thakkar highlighted select stocks for the ...

India's share in global CRDMO market will likely rise to 4.7% by 2029 from 3.8% in 2024, making it an attractive sector, HDFC ...

Divi’s Laboratories shares gained over 3 per cent as analysts flagged 2026 as a potential inflection point, driven by a ...

Citi said it believes Divi's Laboratories' revenue and earnings before interest, tax, depreciation, and amortisation (EBITDA) ...